• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类器官在癌症研究中的作用。

The role of organoids in cancer research.

作者信息

Fang Zhen, Li Peijuan, Du Fengying, Shang Liang, Li Leping

机构信息

Department of Gastroenterological Surgery, Shandong Provincial Hospital of Shandong First Medical University, Jingwuweiqi street, 324, Jinan, 250021, Shandong, China.

Department of Digestive Tumour Translational Medicine, Engineering Laboratory of Shandong Province, Shandong Provincial Hospital, Jinan, 250021, Shandong, China.

出版信息

Exp Hematol Oncol. 2023 Aug 3;12(1):69. doi: 10.1186/s40164-023-00433-y.

DOI:10.1186/s40164-023-00433-y
PMID:37537666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401879/
Abstract

Organoids are established through in vitro 3D culture, and they can mimic the structure and physiological functions of organs or tissues in vivo. Organoids have attracted much attention in recent years. They can provide a reliable technology platform for cancer research and treatment and are a valuable preclinical model for academic research and personalized medicine. A number of studies have confirmed that organoids have great application prospects in new drug development, drug screening, tumour mechanism research, and precision medicine. In this review, we mainly focus on recent advances in the application of organoids in cancer research. We also discussed the opportunities and challenges facing organoids, hoping to indicate directions for the development of organoids in the future.

摘要

类器官是通过体外三维培养建立的,它们可以模拟体内器官或组织的结构和生理功能。近年来,类器官备受关注。它们可为癌症研究和治疗提供可靠的技术平台,是学术研究和个性化医疗中一种有价值的临床前模型。多项研究证实,类器官在新药研发、药物筛选、肿瘤机制研究和精准医学方面具有广阔的应用前景。在本综述中,我们主要关注类器官在癌症研究应用方面的最新进展。我们还讨论了类器官面临的机遇和挑战,希望为类器官未来的发展指明方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/e8171cdbae13/40164_2023_433_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/f30e806694d4/40164_2023_433_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/f74c6ba2dd4d/40164_2023_433_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/e8171cdbae13/40164_2023_433_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/f30e806694d4/40164_2023_433_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/f74c6ba2dd4d/40164_2023_433_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa4/10401879/e8171cdbae13/40164_2023_433_Fig3_HTML.jpg

相似文献

1
The role of organoids in cancer research.类器官在癌症研究中的作用。
Exp Hematol Oncol. 2023 Aug 3;12(1):69. doi: 10.1186/s40164-023-00433-y.
2
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.精准医学中的患者来源类器官:药物筛选、芯片类器官和活体类器官生物样本库。
Front Oncol. 2021 Dec 30;11:762184. doi: 10.3389/fonc.2021.762184. eCollection 2021.
3
Progress and perspective of organoid technology in cancer-related translational medicine.类器官技术在癌症相关转化医学中的进展与展望
Biomed Pharmacother. 2022 May;149:112869. doi: 10.1016/j.biopha.2022.112869. Epub 2022 Mar 28.
4
Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine.癌症类器官在药物筛选和个性化医疗中的进展与应用。
Stem Cell Rev Rep. 2024 Jul;20(5):1213-1226. doi: 10.1007/s12015-024-10714-6. Epub 2024 Mar 27.
5
Organoids: The current status and biomedical applications.类器官:当前现状与生物医学应用
MedComm (2020). 2023 May 17;4(3):e274. doi: 10.1002/mco2.274. eCollection 2023 Jun.
6
Patient-derived cancer organoids for drug screening: Basic technology and clinical application.患者来源的肿瘤类器官用于药物筛选:基础技术与临床应用。
J Gastroenterol Hepatol. 2022 Aug;37(8):1446-1454. doi: 10.1111/jgh.15930. Epub 2022 Jul 7.
7
Tumor Organoid as a Drug Screening Platform for Cancer Research.肿瘤类器官作为癌症研究的药物筛选平台。
Curr Stem Cell Res Ther. 2024;19(9):1210-1250. doi: 10.2174/011574888X268366230922080423.
8
Organoid technology and applications in cancer research.类器官技术及其在癌症研究中的应用。
J Hematol Oncol. 2018 Sep 15;11(1):116. doi: 10.1186/s13045-018-0662-9.
9
[Exploration of organoid in breast cancer related research].[乳腺癌相关研究中类器官的探索]
Sheng Wu Gong Cheng Xue Bao. 2021 Feb 25;37(2):395-403. doi: 10.13345/j.cjb.200285.
10
Living biobank-based cancer organoids: prospects and challenges in cancer research.基于生物样本库的活体癌症类器官:癌症研究中的前景与挑战
Cancer Biol Med. 2022 Jul 21;19(7):965-82. doi: 10.20892/j.issn.2095-3941.2021.0621.

引用本文的文献

1
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
2
Bioprinted Organoids: An Innovative Engine in Biomedicine.生物打印类器官:生物医学中的创新引擎。
Adv Sci (Weinh). 2025 Sep;12(33):e07317. doi: 10.1002/advs.202507317. Epub 2025 Jul 25.
3
Cancer research and the mainstream of biology.癌症研究与生物学主流

本文引用的文献

1
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.患者来源的类器官(PDO)和PDO衍生的异种移植物(PDOX):建立可靠的临床前癌症模型的新机遇。
J Natl Cancer Cent. 2022 Oct 22;2(4):263-276. doi: 10.1016/j.jncc.2022.10.001. eCollection 2022 Dec.
2
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer.ADAR1 介导的 SCD1 RNA 编辑促进胃癌的耐药性和自我更新。
Nat Commun. 2023 May 19;14(1):2861. doi: 10.1038/s41467-023-38581-8.
3
Prostate organoids: emerging experimental tools for translational research.
Front Cell Dev Biol. 2025 Jul 2;13:1623849. doi: 10.3389/fcell.2025.1623849. eCollection 2025.
4
Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy.用于胰腺导管腺癌光动力治疗的仿生肿瘤模型系统
Int J Mol Sci. 2025 Jul 2;26(13):6388. doi: 10.3390/ijms26136388.
5
Cancer-on-a-chip for precision cancer medicine.用于精准癌症医学的芯片上的癌症模型
Lab Chip. 2025 May 16. doi: 10.1039/d4lc01043d.
6
Three-dimensional bioprinted in vitro glioma tumor constructs for synchrotron microbeam radiotherapy dosimetry and biological study using gelatin methacryloyl hydrogel.使用甲基丙烯酰化明胶水凝胶进行三维生物打印的体外胶质瘤肿瘤构建体,用于同步加速器微束放射治疗剂量测定和生物学研究。
Sci Rep. 2025 Apr 22;15(1):13868. doi: 10.1038/s41598-025-88793-9.
7
A Brief History of Cell Culture: From Harrison to Organs-on-a-Chip.细胞培养简史:从哈里森到芯片上的器官
Cells. 2024 Dec 15;13(24):2068. doi: 10.3390/cells13242068.
8
Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources.恶性胸腔积液有助于建立和维持具有多种患者来源肺肿瘤细胞的肿瘤类器官生物样本库。
Exp Hematol Oncol. 2024 Nov 15;13(1):115. doi: 10.1186/s40164-024-00581-9.
9
Molecular and modular intricacies of precision oncology.精准肿瘤学的分子和模块复杂性。
Front Immunol. 2024 Oct 23;15:1476494. doi: 10.3389/fimmu.2024.1476494. eCollection 2024.
10
The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response.溶瘤病毒靶向成纤维细胞对增强抗肿瘤免疫反应的影响。
Heliyon. 2024 Oct 10;10(20):e39204. doi: 10.1016/j.heliyon.2024.e39204. eCollection 2024 Oct 30.
前列腺类器官:转化研究中的新兴实验工具。
J Clin Invest. 2023 May 15;133(10):e169616. doi: 10.1172/JCI169616.
4
Bladder cancer organoids as a functional system to model different disease stages and therapy response.膀胱癌类器官作为一种功能系统,可用于模拟不同疾病阶段和治疗反应。
Nat Commun. 2023 Apr 18;14(1):2214. doi: 10.1038/s41467-023-37696-2.
5
The functional and clinical roles of liquid biopsy in patient-derived models.液体活检在患者衍生模型中的功能和临床作用。
J Hematol Oncol. 2023 Apr 8;16(1):36. doi: 10.1186/s13045-023-01433-5.
6
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice.在体人肠类器官移植入人源化小鼠后免疫组织的发育。
Nat Biotechnol. 2023 Jun;41(6):824-831. doi: 10.1038/s41587-022-01558-x. Epub 2023 Jan 26.
7
Towards a better understanding of diabetes mellitus using organoid models.利用类器官模型深入了解糖尿病。
Nat Rev Endocrinol. 2023 Apr;19(4):232-248. doi: 10.1038/s41574-022-00797-x. Epub 2023 Jan 20.
8
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.利用患者来源的类器官预测局部晚期或转移性肺癌肿瘤的反应:一项真实世界的研究。
Cell Rep Med. 2023 Feb 21;4(2):100911. doi: 10.1016/j.xcrm.2022.100911. Epub 2023 Jan 18.
9
Advancing organoid design through co-emergence, assembly, and bioengineering.通过共现、组装和生物工程推进类器官设计。
Trends Biotechnol. 2023 Jul;41(7):923-938. doi: 10.1016/j.tibtech.2022.12.021. Epub 2023 Jan 16.
10
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.阻断 NMT1 的酶活性抑制 VILIP3 蛋白的 N-豆蔻酰化,从而抑制肝癌进展。
Signal Transduct Target Ther. 2023 Jan 9;8(1):14. doi: 10.1038/s41392-022-01248-9.